Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar 21:7:e34271.
doi: 10.7554/eLife.34271.

HIV-1 Env trimer opens through an asymmetric intermediate in which individual protomers adopt distinct conformations

Affiliations

HIV-1 Env trimer opens through an asymmetric intermediate in which individual protomers adopt distinct conformations

Xiaochu Ma et al. Elife. .

Abstract

HIV-1 entry into cells requires binding of the viral envelope glycoprotein (Env) to receptor CD4 and coreceptor. Imaging of individual Env molecules on native virions shows Env trimers to be dynamic, spontaneously transitioning between three distinct well-populated conformational states: a pre-triggered Env (State 1), a default intermediate (State 2) and a three-CD4-bound conformation (State 3), which can be stabilized by binding of CD4 and coreceptor-surrogate antibody 17b. Here, using single-molecule Fluorescence Resonance Energy Transfer (smFRET), we show the default intermediate configuration to be asymmetric, with individual protomers adopting distinct conformations. During entry, this asymmetric intermediate forms when a single CD4 molecule engages the trimer. The trimer can then transition to State 3 by binding additional CD4 molecules and coreceptor.

Keywords: HIV-1 Envelope; Single molecule FRET; infectious disease; microbiology; molecular biophysics; structural biology; virus; virus entry.

PubMed Disclaimer

Conflict of interest statement

XM, ML, JG, DT, XH, ZZ, HZ, RA, JA, SB, PK, JM No competing interests declared, WM Patent applications pertaining to this work are U.S. Patent Application 13/202,351, Methods and Compositions for Altering Photophysical Properties of Fluorophores via Proximal Quenching (S.C.B., Z.Z.); U.S. Patent Application 14/373,402 Dye Compositions, Methods of Preparation, Conjugates Thereof, and Methods of Use (S.C.B., Z.Z.); and International and US Patent Application PCT/US13/42249 Reagents and Methods for Identifying Anti-HIV Compounds (S.C.B., J.B.M., W.M.). S.C.B. is a co-founder of Lumidyne Corporation

Figures

Figure 1.
Figure 1.. State 3 corresponds to the gp120 conformation of the three-CD4-bound HIV-1 Env trimer.
(A) Representative smFRET trace for unliganded HIV-1NL4-3 Env. (Top) The donor fluorophore (green) was attached to the V1 loop and the acceptor fluorophore (red) was attached to the V4 loop. (Bottom) Corresponding FRET trajectory (blue) with overlaid idealization generated by Hidden Markov Modeling (HMM) (red). (B) (Left) Probability distribution of FRET values compiled from all the individual HIV-1NL4-3 Env molecules (N = number of FRET traces analyzed). The histogram was fitted to a sum of three Gaussian distributions, with means of 0.13, 0.3 and 0.63, which are corresponding to States 1, 3 and 2, as indicated. The percentage indicates the occupancy of each FRET state. Error bars represent standard errors calculated from histograms from three independent sets of FRET traces. (Right) Transition Density Plot (TDP) of all the observed transitions in unliganded HIV-1NL4-3 Env. Color bar shows the scale used to indicate the frequency of each transition. (C, D) sCD4 (0.1 mg/ml) (C) or sCD4D1D2-Igαtp (0.1 mg/ml) (D) was incubated with the virus for 30 min prior to imaging. FRET histogram and TDP are as in (B). (E–G) Probability distributions (left) and TDPs (right) for HIV-1JR-FL Env for the unliganded (E) (Note: FRET histogram and TDP were from previous data set for direct comparison [Herschhorn et al., 2016]), sCD4-bound (0.1 mg/ml) (F) and sCD4D1D2-Igαtp-bound (0.1 mg/ml) (G). (H–J) Probability distributions (left) and TDPs (right) for HIV-1BG505 Env for the unliganded (H), sCD4-bound (0.1 mg/ml) (I) and sCD4D1D2-Igαtp-bound (0.1 mg/ml) (J) viruses are displayed as in HIV-1NL4-3. (K) Schematic illustration of the closed and open conformations of the Env trimer. The unliganded conformation is in blue and CD4-bound conformation is in pink. Green and red starts represent donor and acceptor fluorophores, respectively. Sizes of the stars represent relative change of fluorescence between donor and acceptor dyes and dotted line indicated changes of inter-dye distances.
Figure 1—figure supplement 1.
Figure 1—figure supplement 1.. Peptide insertion sites into the V1 and V4 loops of gp120 of three HIV-1 isolates.
Q3 and A1 peptides were inserted into the V1 and V4 loops of gp120 in HIV-1NL4-3, HIV-1JR-FL, HIV-1BG505, respectively (Munro et al., 2014)(HIV-1BG505, this report).
Figure 1—figure supplement 2.
Figure 1—figure supplement 2.. Infectivity and Env incorporation of single or dually tagged HIV-1BG505 viruses.
Q3 (GQQQLG) or A1 (GDSLDMLLEWSLM) tags were inserted separately or together into the V1 and V4 loops of full-length Q23_BG505 virus. (A) Infectivity was measured from three independent experiments by Gaussia Luciferase assay and normalized to WT (%). (B) Env incorporation into virions was detected by Western blotting using an antiserum to HIV-1 gp120 (NIH AIDS Reagent Program) well as an anti-p24 antibody.
Figure 1—figure supplement 3.
Figure 1—figure supplement 3.. Dually tagged HIV-1BG505 antibodies are neutralized by trimer specific antibodies.
Neutralization of HIV-1 BG505_WT (black) and dually labeled BG505_V1Q3_V4A1 (purple) by the broadly neutralizing antibodies (A) PG9 and (B) PG16. X-axis depicts increasing concentration of antibodies (μg/ml) and the y-axis shows the relative infectivity compared to control in the absence of ligands. Infectivity was measured using the Gaussia Luciferase assay.
Figure 1—figure supplement 4.
Figure 1—figure supplement 4.. smFRET histogram for HIV-1BG505 Env bound to sCD4 and 17b.
HIV-1BG505 Env carrying virions were incubated with sCD4 and 17b (0.1 mg/ml each) at room temperature for 30 min prior to TIR-FM imaging. FRET trajectories were compiled into histogram and fitted into 3-state Gaussian curves.
Figure 2.
Figure 2.. State 2 corresponds to an asymmetric trimer, in which a single CD4 molecule engages HIV-1 Env.
(A) Neutralization curves of WT and D368R HIVNL4-3 viruses by sCD4 and sCD4D1D2-Igαtp. Data represent three independent experiments ± standard deviation. (B) Scheme to illustrate generation of mixed HIV-1 Env trimer 1, in which the two unlabeled protomers contained the D368R mutation to prevent CD4 binding, and the CD4-binding competent WT protomer carried the donor and acceptor fluorophores (green, red stars in scheme above). (C) Scheme to illustrate generation of mixed HIV-1 trimer 2, in which sCD4 can only engage gp120 domains adjacent to the labeled domain. Given the co-transfection protocol of indicated HIV-1 plasmids, only 50% of all trimers are expected to exhibit this configuration. 25% of trimers are expected to carry D368R mutation in all three protomers and the remaining 25% would carry two CD4-binding competent protomers next to the labeled mutant gp120. (D) FRET histogram as in Figure 1 for the mixed HIV-1NL4-3 Env trimer 1. (E) FRET histogram for the mixed HIV-1NL4-3 Env trimer 2. Neutralization curves for HIV-1JR-FL (F) or HIV-1BG505 (I) were shown as in HIV-1NL4-3. FRET histograms for mixed HIV-1JR-FL (G–H) and HIV-1BG505 (J–K) Env trimer 1 and 2 are shown as HIV-1NL4-3. Viruses were incubated with sCD4 (0.1 mg/ml) or sCD4D1D2-Igαtp (0.01 mg/ml) for 30 min prior to imaging as indicated. (L) Schematic illustration of the asymmetric opening of the Env trimer. The CD4-bound conformation is in pink, and the conformational intermediate in the asymmetric trimer is in purple. The purple x indicates the D368R mutation. Green and red stars represent donor and acceptor fluorophores, respectively. Sizes of the stars represent relative change of fluorescence between donor and acceptor dyes and dotted line indicated changes of inter-dye distances.
Figure 2—figure supplement 1.
Figure 2—figure supplement 1.. D368R carrying Envs are expressed and incorporated into virions similar to wild-type.
HIV-1 containing WT or D368R Env were produced in HEK293 cells and viral supernatants collected 40 hr post-transfection. Virus was concentrated by centrifugation at 20,000 g and analyzed by SDS-PAGE and Western blot analyses using the anti-Env antibody 2G12 or patient serum (NIH AIDS Reagent Program) to detect Env of HIV-1NL4-3 and HIV-1JR-FL w, or HIV-1BG505, respectively, and anti-p24 to detect capsid.
Figure 2—figure supplement 2.
Figure 2—figure supplement 2.. Infectivity of HIV-1D368R viruses.
Infectivity of WT and D368R containing HIV-1 isolates was determined from three independent measurements with ±standard deviation (SD); presented normalized to WT infectivity (%).
Figure 2—figure supplement 3.
Figure 2—figure supplement 3.. D368R inhibits sCD4 and sCD4D1D2-Igαtp binding of all three HIV-1 Envs.
(A) FRET histograms as in Figure 1 for the unliganded (left), sCD4-bound (middle) and sCD4D1D2-Igαtp-bound (right) HIV-1NL4-3 Envs carrying the D368R mutation in all protomers. (B) FRET histograms as in (A) for the HIV-1JR-FL Env carrying the D368R mutation in all protomers. (C) FRET histograms as in (A) for the HIV-1BG505 Env carrying the D368R mutation in all protomers. sCD4 (0.1 mg/ml) and sCD4D1D2-Igαtp (0.01 mg/ml) were incubated for 30 min prior to imaging.
Figure 3.
Figure 3.. Binding of additional CD4 molecules or coreceptors completely opens the Env trimer.
(A) Scheme to illustrate generation of mixed HIV-1 Env trimer 3, in which two unlabeled protomers are CD4-binding competent and the one protomer carrying the donor and acceptor fluorophores (green, red stars in scheme above) is CD4-binding defective because it has the D368R mutation. (B–D) FRET histograms as in Figure 1 for the mixed HIV-1 Env trimer 3. sCD4D1D2-Igαtp (0.01 mg/ml) was incubated with the virus for 30 min prior to imaging. (E) Scheme to illustrate generation of mixed HIV-1 Env trimer 2, as in Figure 2. (F–H) FRET histograms as in Figure 1 for the mixed HIV-1 Env trimer 2. sCD4 (0.1 mg/ml) and 17b (0.1 mg/ml) were incubated with the virus for 30 min prior to imaging. (I) Schematic illustration of the further activation of the Env trimer. from the asymmetric intermediate. The CD4-bound conformation is in pink, and the conformational intermediate in the asymmetric trimer is in purple. The purple x indicates the D368R mutation. Green and red starts represent donor and acceptor fluorophores, respectively. Sizes of the stars represent relative change of fluorescence between donor and acceptor dyes and dotted line indicated changes of inter-dye distances.
Figure 3—figure supplement 1.
Figure 3—figure supplement 1.. Model for the activation of the HIV-1 Env trimer through asymmetric intermediates.
The Env configuration of the structural trimer intermediates depicts the conformational state of each protomer (State 1 = blue, State 2 = purple, State 3 = pink) within the trimer. See text for details.
Figure 4.
Figure 4.. Kinetic analysis of HIV-1 Env binding to CD4.
Differences in free energies (ΔG°ij) between the FRET states, and the changes in activation energies (ΔΔGij) arising from sCD4 and sCD4D1D2-Igαtp binding to (A) HIV-1NL4-3 (B) HIV-1JR-FL and (C) HIV-1BG505. ΔG°ij values were calculated from the occupancies of each FRET state in the FRET histograms. ΔΔGij values were calculated from the rate constants for the observed transitions for the unliganded (black), sCD4-bound (green) and sCD4D1D2-Igαtp-bound (blue) HIV-1 Env. The dotted arrow lines indicate the actual ΔΔGij of the forward and backward transitions while the solid line in between indicate the averaged value of the two. Energies are displayed in units of kBT, where kB is Boltzmann constant, and T is temperature.
Figure 4—figure supplement 1.
Figure 4—figure supplement 1.. Survival probability distributions for transitions observed in HIV-1NL4-3 Env.
(A–C) Survival probability distributions (gray) for each transition for the unliganded (A), sCD4-bound (B), and sCD4D1D2-Igαtp-bound (C) HIV-1NL4-3 Env. Each distribution was fit to the sum of two exponential distributions (y = A1 exp k1t + A2 exp k2t) (red). R2 of curve fitting was indicated in each panel.
Figure 4—figure supplement 2.
Figure 4—figure supplement 2.. Survival probability distributions for transitions observed in HIV-1JR-FL Env.
Survival probability distributions as in Figure 4—figure supplement 1 for HIV-1JR-FL Env.
Figure 4—figure supplement 3.
Figure 4—figure supplement 3.. Survival probability distributions for transitions observed in HIV-1BG505 Env.
Survival probability distributions as in Figure 4—figure supplement 1 for HIV-1BG505 Env.

Similar articles

Cited by

References

    1. Aitken CE, Marshall RA, Puglisi JD. An oxygen scavenging system for improvement of dye stability in single-molecule fluorescence experiments. Biophysical Journal. 2008;94:1826–1835. doi: 10.1529/biophysj.107.117689. - DOI - PMC - PubMed
    1. Arthos J, Cicala C, Steenbeke TD, Chun TW, Dela Cruz C, Hanback DB, Khazanie P, Nam D, Schuck P, Selig SM, Van Ryk D, Chaikin MA, Fauci AS. Biochemical and biological characterization of a dodecameric CD4-Ig fusion protein: implications for therapeutic and vaccine strategies. The Journal of Biological Chemistry. 2002;277:11456–11464. doi: 10.1074/jbc.M111191200. - DOI - PubMed
    1. Bennett A, Liu J, Van Ryk D, Bliss D, Arthos J, Henderson RM, Subramaniam S. Cryoelectron tomographic analysis of an HIV-neutralizing protein and its complex with native viral gp120. Journal of Biological Chemistry. 2007;282:27754–27759. doi: 10.1074/jbc.M702025200. - DOI - PubMed
    1. Blumenthal R, Durell S, Viard M. HIV entry and envelope glycoprotein-mediated fusion. Journal of Biological Chemistry. 2012;287:40841–40849. doi: 10.1074/jbc.R112.406272. - DOI - PMC - PubMed
    1. Caskey M, Klein F, Lorenzi JC, Seaman MS, West AP, Buckley N, Kremer G, Nogueira L, Braunschweig M, Scheid JF, Horwitz JA, Shimeliovich I, Ben-Avraham S, Witmer-Pack M, Platten M, Lehmann C, Burke LA, Hawthorne T, Gorelick RJ, Walker BD, Keler T, Gulick RM, Fätkenheuer G, Schlesinger SJ, Nussenzweig MC. Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117. Nature. 2015;522:487–491. doi: 10.1038/nature14411. - DOI - PMC - PubMed

Publication types

MeSH terms